We are pleased to invite you to the AsiaTIDES meeting taking place February 26-28, 2019 in Tokyo, Japan. AsiaTIDES is the only event in Asia bringing together science, technologies, and partners to accelerate oligonucleotide and peptide molecules to market.
By joining us, you will:
- Meet 250+ oligonucleotide and peptide scientists and executives to fast-track your research to the clinic and beyond by collaborating with leading pharma, biotechs, academia and solution providers from North America, Europe, and Asia.
- Hear case studies, best practices and lessons learned from global oligonucleotide and peptide developers currently in phase 2/3 clinical trials. Ensure product approval by hearing regulatory guidance and roadmaps to successful IND/IMPD submissions from industry leaders.
- Connect with 20+ global technology leaders in the exhibit hall who will assist you with improving your process development, analytical and manufacturing efforts. The exhibit hall also features peer-submitted posters that contain new and unpublished research from global scientists working across all phases of oligonucleotide and peptide development.
- Hear from world-renowned speakers like Jesper Lau of Novo Nordisk A/S, Thazha Prakash of Ionis Pharmaceuticals, Mano Manoharan or Alnylam Pharmaceuticals, and Chandra Vargeese of WAVE Life Sciences.
For more detailed information and to register, visit: www.AsiaTIDESEvent.com. For a $200 savings, use VIP code ‘RNASociety200’ at checkout.
We look forward to seeing you in Tokyo!